NVNO vs. DRTS, NYXH, SMTI, ZIMV, SKIN, CATX, BWAY, TCMD, BSGM, and STIM
Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Alpha Tau Medical (DRTS), Nyxoah (NYXH), Sanara MedTech (SMTI), ZimVie (ZIMV), Beauty Health (SKIN), Perspective Therapeutics (CATX), Brainsway (BWAY), Tactile Systems Technology (TCMD), Biosig Technologies (BSGM), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry.
enVVeno Medical vs. Its Competitors
Alpha Tau Medical (NASDAQ:DRTS) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.
Alpha Tau Medical currently has a consensus price target of $8.00, indicating a potential upside of 145.40%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Alpha Tau Medical is more favorable than enVVeno Medical.
In the previous week, Alpha Tau Medical had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for enVVeno Medical. Alpha Tau Medical's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 16.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Alpha Tau Medical has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500.
Alpha Tau Medical is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
Alpha Tau Medical's return on equity of -49.48% beat enVVeno Medical's return on equity.
Summary
Alpha Tau Medical beats enVVeno Medical on 9 of the 12 factors compared between the two stocks.
Get enVVeno Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
enVVeno Medical Competitors List
Related Companies and Tools
This page (NASDAQ:NVNO) was last updated on 7/10/2025 by MarketBeat.com Staff
